In addition, CD34, EDIL3, and TPM3 were positively correlated with signaling pathways related to tumor immune response, invasion, and metastasis, particularly the IL6/JAK/STAT3, inflammatory response, TNF-α signaling via NF-kB, and epithelial-mesenchymal transition. The gene discussed is CD34; the disease is neoplasm.